Bayer Statement on Solicitor General’s Amicus Brief in the Hardeman Appeal
Bayer today issued the following statement on the Solicitor General’s Amicus Brief in the Hardeman appeal:
“The company continues to believe there are strong legal arguments to support Supreme Court review and reversal in Hardeman, as its petition and the many amicus briefs filed in support of the petition underscore. Indeed, the expert U.S. agency, the Environmental Protection Agency, has consistently found that glyphosate-based herbicides can be used safely and are not carcinogenic. Therefore, a cancer warning would be false and misleading and would be preempted by the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
“The decision to accept or deny review rests with the Supreme Court, which will consider the views of the parties – including an additional brief to be filed by the company – as well as the brief from the Solicitor General. Regardless of the final outcome at the Supreme Court, the company is fully prepared to move forward with its five-point plan, manage litigation risks and bring closure to the Roundup™ litigation.”